Calling all bioxcel therapeutics, inc. (btai) investors: contact bronstein, gewirtz & grossman, llc to claim your losses!

New york , july 10, 2023 /prnewswire/ -- attorney advertising -- bronstein, gewirtz & grossman, llc, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against bioxcel therapeutics, inc. ("bioxcel" or the "company") (nasdaq: btai) and certain of its officers. class definition: this lawsuit seeks to recover damages against defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired bioxcel securities between december 15, 2021 and june 28, 2023, inclusive (the "class period").
BTAI Ratings Summary
BTAI Quant Ranking